Skip to main content
. 2023 Nov 22;26(12):108504. doi: 10.1016/j.isci.2023.108504

Figure 5.

Figure 5

Suppression of Type 2 responses maintained upon oral exposure prior to vaccination with various adjuvants

Experimental timeline from Figure 1A was used with various adjuvants.

(A) OVA-IgG1 titers and secreted IL-4 upon OVA-re-stimulation of splenocytes after 72 h.

(B) OVA-IgG2c titers and secreted IFNγ upon OVA-re-stimulation of splenocytes after 72 h.

For each adjuvant, data are pooled from 2 to 3 independent experiments and represented as mean ± SD. Unpaired t tests were used for statistical analysis. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.